4.5 Article

Dehydroepiandrosterone Administration or Gαq Overexpression Induces β-Catenin/T-Cell Factor Signaling and Growth via Increasing Association of Estrogen Receptor-β/Dishevelled2 in Androgen-Independent Prostate Cancer Cells

期刊

ENDOCRINOLOGY
卷 151, 期 4, 页码 1428-1440

出版社

ENDOCRINE SOC
DOI: 10.1210/en.2009-0885

关键词

-

资金

  1. National Institutes of Health (Bethesda, MD)

向作者/读者索取更多资源

beta-Catenin/T-cell factor signaling (beta-CTS) plays multiple critical roles in carcinogenesis and is blocked by androgens in androgen receptor (AR)-responsive prostate cancer (PrCa) cells, primarily via AR sequestration of beta-catenin from T-cell factor. Dehydroepiandrosterone (DHEA), often used as an over-the-counter nutritional supplement, is metabolized to androgens and estrogens in humans. The efficacy and safety of unregulated use of DHEA are unclear. We now report that DHEA induces beta-CTS via increasing association of estrogen receptor (ER)-beta with Dishevelled2 (Dvl2) in AR nonresponsive human PrCa DU145 cells, a line of androgen-independent PrCa (AiPC) cells. The induction is temporal, as assessed by measuring kinetics of the association of ER beta/Dvl2, protein expression of the beta-CTS targeted genes, c-Mycandcyclin D1, and cell growth. However, in PC-3 cells, another human AiPC cell line, DHEA exerts no detectible effects, partly due to their lower expression of G alpha-subunits and DHEA down-regulation of ER beta/Dvl2 association. When G alpha q is over-expressed in PC-3 cells, beta-CTS is constitutively induced, including increasing c-Myc and cyclin D1 protein expression. This effect involved increasing associations of G alpha q/Dvl2 and ER alpha/Dvl2 and promoted cell growth. These activities require ER beta in DU-145 and PC-3 cells because they are blocked by ICI 182-780 treatment inactivating ER beta, small interfering RNA administration depleting ER beta, or AR overexpression arresting ER beta. These data suggest that novel pathways activating beta-CTS play roles in the progression of AiPC. Although DHEA may enhance PrCa cell growth via androgenic or estrogenic pathways, the effects of DHEA administration on clinical prostate function remain to be determined. (Endocrinology 151: 1428-1440, 2010)

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据